Masatoshi Kochi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Masatoshi Kochi has a total of 26 co-authors. Here are the top co-authors by number of shared publications:
Haruki Sada
Department of Gastroenterological and Transplant Surgery Applied Life Sciences Institute of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
2 shared publications- Hideki Ohdan
Department of Gastroenterological and Transplant Surgery Graduate School of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
2 shared publications - Shoichiro Mukai
Department of Surgery, Chugokurosai Hospital, 1-5-1, Hirotagaya, Kure City, Hiroshima 737-0193, Japan
2 shared publications Hideki Ohdan
Department of Gastroenterological and Transplant Surgery Applied Life Sciences Institute of Biomedical and Health Sciences Hiroshima University Hiroshima Japan
1 shared publicationHiroaki Niitsu
Department of Medicine Vanderbilt University Medical Center Nashville TN USA
1 shared publicationHirotaka Tashiro
Department of Surgery National Hospital Organization Kure Medical Center and Chugoku Cancer Center Hiroshima Japan
1 shared publication
Latest Publications
- Open Access
- 13 November 2026
- Published by Wiley in World Journal of Surgery
Predicting Blood Flow in Reconstructed Intestines Based on Abdominal Aortic Calcification and Clinical Effects of Left Colic Artery Preservation in Colorectal Cancer Surgery: A Subanalysis of the HiSCO‐09 Study
Aim: To clarify the relationship between the abdominal aortic calcification score on preoperative computed tomography and intraoperative regional tissue oxygen saturation (rSO 2 ), assess the feasibility of predicting perfusion impairment through imaging, and evaluate whether left colic artery preservation improves blood flow and reduces the risk of anastomotic leakage in patients with impaired perfusion. Methods: In this subanalysis of the HiSCO‐09 trial, rSO 2 was measured using INVOS in the intestinal segment at the intended intestinal anastomosis site following mesenteric preparation as a blood flow indicator. Patients were categorized according to the abdominal aortic calcification score based on preoperative computed tomography findings into low (≤ 2.13 mL) and high (> 2.13 mL) groups. Results: Of the 282 patients, the high abdominal aortic calcification group included 135 patients. Compared with the low group, the high group showed significantly higher incidence of anastomotic leakage (4.8% vs. 12.6%, p = 0.019) and consistently lower rSO 2 values. Abdominal aortic calcification score correlated negatively with rSO 2 at the anastomosis site ( p = 0.011). Within the high group, left colic artery preservation was associated with higher rSO 2 and a lower incidence of anastomotic leakage ( p = 0.032). Conclusions: Preoperative abdominal aortic calcification assessment was weakly associated with reduced intraoperative rSO 2 . Exploratory subgroup analysis indicated that left colic artery preservation was associated with better perfusion and fewer anastomotic leakages in patients with high calcification. Although insufficient as a stand‐alone predictor, abdominal aortic calcification may serve as a complementary factor in multifactorial preoperative risk assessments for future prospective evaluation.
- 13 November 2026
- Published by Wiley in World Journal of Surgery
Open AccessPredicting Blood Flow in Reconstructed Intestines Based on Abdominal Aortic Calcification and Clinical Effects of Left Colic Artery Preservation in Colorectal Cancer Surgery: A Subanalysis of the HiSCO‐09 Study
Aim: To clarify the relationship between the abdominal aortic calcification score on preoperative computed tomography and intraoperative regional tissue oxygen saturation (rSO 2 ), assess the feasibility of predicting perfusion impairment through imaging, and evaluate whether left colic artery preservation improves blood flow and reduces the risk of anastomotic leakage in patients with impaired perfusion. Methods: In this subanalysis of the HiSCO‐09 trial, rSO 2 was measured using INVOS in the intestinal segment at the intended intestinal anastomosis site following mesenteric preparation as a blood flow indicator. Patients were categorized according to the abdominal aortic calcification score based on preoperative computed tomography findings into low (≤ 2.13 mL) and high (> 2.13 mL) groups. Results: Of the 282 patients, the high abdominal aortic calcification group included 135 patients. Compared with the low group, the high group showed significantly higher incidence of anastomotic leakage (4.8% vs. 12.6%, p = 0.019) and consistently lower rSO 2 values. Abdominal aortic calcification score correlated negatively with rSO 2 at the anastomosis site ( p = 0.011). Within the high group, left colic artery preservation was associated with higher rSO 2 and a lower incidence of anastomotic leakage ( p = 0.032). Conclusions: Preoperative abdominal aortic calcification assessment was weakly associated with reduced intraoperative rSO 2 . Exploratory subgroup analysis indicated that left colic artery preservation was associated with better perfusion and fewer anastomotic leakages in patients with high calcification. Although insufficient as a stand‐alone predictor, abdominal aortic calcification may serve as a complementary factor in multifactorial preoperative risk assessments for future prospective evaluation.
- Open Access
- 6 July 2020
- Published by Wiley in Cancer Science
- Vol. 111 (10) , 3540-3549
Oncogenic mutation in RAS‐RAF axis leads to increased expression of GREB1, resulting in tumor proliferation in colorectal cancer
BRAFV600E mutation accounts for up to 90% of all BRAF mutations in human colorectal cancer (CRC), and constitutively activates the MEK‐MAPK pathway. It is recognized that neutralizing mAbs for epidermal growth factor receptor alone are not effective for CRC with BRAFV600E mutation. Therefore, there is increasing interest in identification of the possible therapeutic targets in downstream of BRAF mutation in CRCs. To address this, we studied genome engineered mouse models for colonic neoplasia that has BrafV600E mutation on the basis of Apc inactivation, induced in 2 distinct Cre mouse models, CDX2P‐G22Cre and CDX2P‐CreERT2 mice. We carried out oligonucleotide microarray analysis for colonic neoplasia generated in these mouse models, and compared gene expression profiles among Kras/Braf WT, Kras‐mutated, and Braf‐mutated mouse colon tumors to seek new molecular targets corresponding to the KRAS‐BRAF‐MAPK axis. We found that the expression of the growth regulation by estrogen in breast cancer protein 1 (Greb1) was the most upregulated gene in Braf‐mutated mouse tumors compared to Kras/Braf WT counterparts. The silencing of GREB1 significantly reduced the proliferation and tumorigenesis of CRC cell lines, whereas the overexpression of GREB1 promoted cell proliferation. Although GREB1 was first identified as a hormone‐responsive gene mediating estrogen‐stimulated cell proliferation in endometriosis, breast, and ovarian cancers, these results suggest that RAS‐RAF‐MAPK signaling upregulates GREB1 expression in CRC, resulting in cellular proliferation. Thus, GREB1 is a possible therapeutic target for CRCs with BrafV600E mutation.
- 6 July 2020
- Published by Wiley in Cancer Science
- Vol. 111 (10) , 3540-3549
Open AccessOncogenic mutation in RAS‐RAF axis leads to increased expression of GREB1, resulting in tumor proliferation in colorectal cancer
BRAFV600E mutation accounts for up to 90% of all BRAF mutations in human colorectal cancer (CRC), and constitutively activates the MEK‐MAPK pathway. It is recognized that neutralizing mAbs for epidermal growth factor receptor alone are not effective for CRC with BRAFV600E mutation. Therefore, there is increasing interest in identification of the possible therapeutic targets in downstream of BRAF mutation in CRCs. To address this, we studied genome engineered mouse models for colonic neoplasia that has BrafV600E mutation on the basis of Apc inactivation, induced in 2 distinct Cre mouse models, CDX2P‐G22Cre and CDX2P‐CreERT2 mice. We carried out oligonucleotide microarray analysis for colonic neoplasia generated in these mouse models, and compared gene expression profiles among Kras/Braf WT, Kras‐mutated, and Braf‐mutated mouse colon tumors to seek new molecular targets corresponding to the KRAS‐BRAF‐MAPK axis. We found that the expression of the growth regulation by estrogen in breast cancer protein 1 (Greb1) was the most upregulated gene in Braf‐mutated mouse tumors compared to Kras/Braf WT counterparts. The silencing of GREB1 significantly reduced the proliferation and tumorigenesis of CRC cell lines, whereas the overexpression of GREB1 promoted cell proliferation. Although GREB1 was first identified as a hormone‐responsive gene mediating estrogen‐stimulated cell proliferation in endometriosis, breast, and ovarian cancers, these results suggest that RAS‐RAF‐MAPK signaling upregulates GREB1 expression in CRC, resulting in cellular proliferation. Thus, GREB1 is a possible therapeutic target for CRCs with BrafV600E mutation.
- 23 October 2018
- Published by Springer Nature in Surgical Endoscopy
- Vol. 33 (2) , 639-643
Surgical techniques for advanced transverse colon cancer using the pincer approach of the transverse mesocolon
Laparoscopic surgery for colorectal cancer, not only early cancer but also advanced cancer, has become standardized by some randomized controlled studies. However, cases involving advanced transverse colon cancer were excluded from these studies due to the technical difficulty of the surgery. Hence, laparoscopic surgery for advanced transverse colon cancer is still a theme that we need to overcome. To solve these issues, it is necessary to establish a standardized approach and surgical technique.
- 23 October 2018
- Published by Springer Nature in Surgical Endoscopy
- Vol. 33 (2) , 639-643
Surgical techniques for advanced transverse colon cancer using the pincer approach of the transverse mesocolon
Laparoscopic surgery for colorectal cancer, not only early cancer but also advanced cancer, has become standardized by some randomized controlled studies. However, cases involving advanced transverse colon cancer were excluded from these studies due to the technical difficulty of the surgery. Hence, laparoscopic surgery for advanced transverse colon cancer is still a theme that we need to overcome. To solve these issues, it is necessary to establish a standardized approach and surgical technique.